Trial Profile
A follow-up study to evaluate long-term safety and outcomes of infants born to mothers participating in retosiban treatment studies
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Retosiban (Primary)
- Indications Preterm labour
- Focus Adverse reactions
- Sponsors GSK
- 19 Mar 2015 New trial record